Remove 2026 Remove Healthcare Provider Remove Patients
article thumbnail

Reaching Crucial Hispanic Patient Audiences

PM360

One fast-growing group in particular that requires a patient-centric and culturally relevant approach to marketing is the Hispanic audience, which is extremely diverse. The patient landscape continues to evolve. By 2026, the U.S. One immediate benefit of inclusive marketing—helping bridge barriers with healthcare providers.

article thumbnail

Why we need to support healthcare’s vital acceleration

pharmaphorum

Let me explain our four reasons for making healthcare a priority in greater detail: Firstly, healthcare’s historic acceleration means investments, both public and private, and revenues are likely to grow steadily. The Covid-19 pandemic made healthcare professionals focus on digital medicine, as they sought to treat patients remotely.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Connected customer data: a golden opportunity for pharma marketers

pharmaphorum

Its ability to accelerate R&D programmes, energise real-time clinical decision making and sharpen connections between pharma organisations and clients is clear and they can combine to positively impact patient outcomes. billion by 2026, according to research by the Business Research Company. billion in 2021 to $9.23 References.

article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

Health systems will buy or establish an insurance plan to serve as an extension of their continuum of care, a means of directing referral streams to increase revenue and securing control over clinical and formulary decisions for patients.

article thumbnail

Specialty Treatments Require a New Approach to Affordability

PM360

As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. Insurance approval and distribution for specialty drugs can cause significant treatment delays up to three to four weeks for many patients.

article thumbnail

Making Sense of the Latest Changes to the Market Access Landscape

PM360

However, Medicare will only be able to negotiate prices for 10 Part D drugs in 2026, another 15 Part D drugs in 2027, another 15 Part D and Part B drugs in 2028, and another 20 Part D and Part B drugs for 2029 and subsequent years. Impact Beyond Medicare The IRA won’t just impact negotiation with the government either. Reference: 1.

article thumbnail

Leaders from Boston Children’s Hospital, Google Cloud, MedCity News, Edgilty Inc, and Clarify Health discuss the future of AI in healthcare

Clarify Health

Artificial intelligence (AI) has the potential to affect healthcare in profound ways — propelling better data-driven decisions on diagnoses, treatments, and population health management. health system realize $150 billion in savings by 2026. During the panel, Dr. Ramadoss gave examples of AI applications in healthcare.